Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 1 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-07-20 Ring Christine General Counsel Sale −1,200 $27.00 $32K 805
2021-07-20 Ring Christine General Counsel Exercise or conversion · Employee Stock Option (right to buy) −1,200 112,066
2021-07-12 Beaurang Pierre Chief Business Officer Exercise or conversion +7,500 $1.11 $8K 11,830
2021-07-12 Beaurang Pierre Chief Business Officer Sale −7,100 $23.88 $170K 4,730
2021-07-12 Beaurang Pierre Chief Business Officer Sale −400 $24.73 $10K 4,330
2021-07-12 Beaurang Pierre Chief Business Officer Exercise or conversion · Employee Stock Option (right to buy) −7,500 14,062
2021-07-01 Hansen Gwenn Chief Scientific Officer Exercise or conversion +400 $7.26 $3K 14,204
2021-07-01 Hansen Gwenn Chief Scientific Officer Sale −400 $26.76 $11K 13,804
2021-07-01 Hansen Gwenn Chief Scientific Officer Exercise or conversion · Employee Stock Option (right to buy) −400 71,866
2021-06-10 Ring Christine General Counsel Exercise or conversion +1,200 $1.86 $2K 2,005
2021-06-10 Ring Christine General Counsel Sale −1,000 $29.18 $29K 1,005
2021-06-10 Ring Christine General Counsel Sale −200 $30.52 $6K 805
2021-06-10 Ring Christine General Counsel Exercise or conversion · Employee Stock Option (right to buy) −1,200 113,266
2021-06-10 Beaurang Pierre Chief Business Officer Exercise or conversion +7,500 $1.11 $8K 11,830
2021-06-10 Beaurang Pierre Chief Business Officer Sale −6,000 $29.15 $175K 5,830
2021-06-10 Beaurang Pierre Chief Business Officer Sale −1,100 $30.01 $33K 4,730
2021-06-10 Beaurang Pierre Chief Business Officer Sale −400 $30.90 $12K 4,330
2021-06-10 Beaurang Pierre Chief Business Officer Exercise or conversion · Employee Stock Option (right to buy) −7,500 21,562
2021-06-01 Hansen Gwenn Chief Scientific Officer Exercise or conversion +400 $7.26 $3K 14,204
2021-06-01 Hansen Gwenn Chief Scientific Officer Sale −400 $27.74 $11K 13,804

Page 33 of 42 · 829 trades